By Belleruth Naparstek — 2011
There are several studies claiming a 70-percent improvement rate for returning warriors who are treated for combat stress with various cognitive behavioral therapies and/or prolonged exposure strategies. But this is a misleading number.
Read on www.huffpost.com
CLEAR ALL
The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.
1